Group One Trading
BCAB icon

Group One Trading’s BioAtla BCAB Stock Holding History

Group One Trading’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-62
Closed -$2.13K – 8142
2025
Q3 		$2.13K Sell
62
-172
-74% -$3.97K ﹤0.01% 7876
2025
Q2 		$4.63K Buy
234
+184
+368% +$3.73K ﹤0.01% 7109
2025
Q1 		$867 Hold
50
– – ﹤0.01% 7203
2024
Q4 		$1.48K Sell
50
-888
-95% -$74.5K ﹤0.01% 6814
2024
Q3 		$82.5K Buy
+938
New +$78.7K ﹤0.01% 4325
2024
Q2 		– Sell
-124
Closed -$21.3K – 6714
2024
Q1 		$21.3K Sell
124
-574
-82% -$71.3K ﹤0.01% 5370
2023
Q4 		$85.9K Buy
+698
New +$60.5K ﹤0.01% 4589
2023
Q3 		– Sell
-22
Closed -$3.3K – 7645
2023
Q2 		$3.3K Buy
22
+10
+83% +$1.72K ﹤0.01% 6895
2023
Q1 		$1.61K Buy
12
+6
+100% +$1.08K ﹤0.01% 6663
2022
Q4 		$2.48K Sell
6
-4,394
-100% -$1.82M ﹤0.01% 6589
2022
Q3 		$1.69M Buy
+4,400
New +$1.44M ﹤0.01% 2062
2022
Q2 		– Sell
-20
Closed -$5K – 7804
2022
Q1 		$5K Buy
+20
New +$8.37K ﹤0.01% 7440

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's BCAB Position: Q4 2025 in Review

Group One Trading sold out of BioAtla (BCAB) in Q4 2025, closing a stake of 23 shares — an estimated $795 sold.

Group One Trading first reported a position in BCAB in Q3 2021 and held it in 14 quarters. The position peaked at $157K in Q2 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • Group One Trading reported no remaining BioAtla position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 23 BioAtla shares in Q4 2025, an estimated $795.
  • Group One Trading first reported a position in BioAtla in Q3 2021 and held it in 14 quarters.
  • Group One Trading's BioAtla position peaked at $157K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.